Skip to main content

Table 3 Unadjusted associations [odds ratio (95% CI)] between ‘high sugar, high fibre, high energy density and low fat’ DP z-scores and cardiometabolic risk factors in adolescents aged 13 years recruited from three southern states of Peninsular Malaysia

From: Associations of an empirical dietary pattern with cardiometabolic risk factors in Malaysian adolescents

Cardiometabolic risk factors

Male

Female

Total

2nd tertile vs 1st tertile

3rd tertile vs 1st tertile

2nd tertile vs 1st tertile

3rd tertile vs 1st tertile

2nd tertile vs 1st tertile

3rd tertile vs 1st tertile

Overweight/Obese, n = 582

0.9 (0.4,1.9)

0.7 (0.3,1.6)

0.9 (0.5,1.5)

0.8 (0.5,1.4)

0.9 (0.6,1.4)

0.8 (0.5,1.2)

Abdominal Obesity, n = 581

0.8 (0.3,2.7)

1.5 (0.5,4.5)

0.9 (0.5,1.9)

0.4 (0.19,1.0)

0.9(0.5,1.7)

0.7(0.4,1.3)

Dyslipidaemia, n = 336

0.7 (0.1,3.9)

2.9 (0.8,10.9)

1.9 (0.9,3.9)

2.0 (0.9,4.2)

1.7 (0.9,3.3)

2.3* (1.2,4.3)

Elevated blood glucose (≥5.60 mmol/L), n = 336

4.5 (0.4,45.7)

8.1 (0.9,73.8)

0.0 (0.0,0.0)

0.9 (0.2,3.8)

0.6 (0.1,2.5)

2.0 (0.6,6.1)

Elevated total cholesterol (≥5.20 mmol/L), n = 336

0.7 (0.1,3.9)

2.9 (0.8,10.9)

1.9 (0.9,3.9)

2.0 (0.9,4.2)

1.7 (0.9,3.3)

2.3* (1.2,4.3)

Lower HDL-cholesterol level (≤1.03 mmol/L), n = 336

0.7 (0.1,7.9)

3.0 (0.5,17.9)

0.3 (0.1,1.8)

0.5 (0.1,2.3)

0.4 (0.1,1.7)

1.0 (0.4,3.1)

Elevated LDL-cholesterol (≥4.12 mmol/L), n = 336

1.2 (0.4,3.1)

2.1 (0.8,5.4)

1.6 (0.9,3.1)

1.6 (0.8,3.0)

1.6 (0.9,2.6)

1.8* (1.0,3.0)

Elevated triglycerides (≥1.70 mmol/L), n = 336

0.7 (0.1,7.9)

0.7 (0.1,7.9)

2.7 (0.3,26.6)

4.9 (0.6,42.7)

1.4 (0.3,6.2)

2.2 (0.5,8.8)

Elevated serum insulin (≥25.0 uIU/mL), n = 336

1.4 (0.2,10.6)

4.0 (0.7,22.1)

0.6 (0.2,2.0)

0.6 (0.2,2.1)

0.8(0.8,2.1)

1.2 (0.5,3.0)

Abnormal HOMA-IR level (≥4.0 unit), n = 336

2.4 (0.7,22.1)

4.1* (1.1,14.8)

1.2 (0.6,2.5)

0.9 (0.4,1.9)

1.5 (0.8,2.8)

1.4 (0.7,2.6)

  1. *p < 0.05 is considered significant. HDL-C High Density Lipoprotein Cholesterol, LDL-C Low Density Lipoprotein Cholesterol, HOMA-IR Homeostatic Model Assessment of Insulin Resistance